MedTrace Logo

Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study

NCT06383754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-04-25

No results posted yet for this study

Summary

This prospective randomized controlled trial will be conducted to investigate Clareon intraocular lens (IOL) stability in vitrectomy patients. The investigator plans to target the patients undergoing cataract surgery. A randomized study will be conducted with 2 arms, one with Clareon IOL versus a second arm using the Tecnis 1 In this non-inferiority study, the investigator will compare Clareon IOL from Alcon with the existing Tecnis 1 IOL from Precision Lens which is the commonly used intraocular lens in combined vitrectomy cases in Hong Kong.

Conditions

  • Senile Cataract
  • Epiretinal Membrane
  • Vitreous Hemorrhage

Interventions

DEVICE

Clareon

Monofocal intraocular lens

DEVICE

Tecnis 1

Monofocal 1 Piece intraocular lens

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Nicholas Fung · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-07
Primary Completion
2024-03-08
Completion
2024-03-15

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06383754 on ClinicalTrials.gov